These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8377241)

  • 1. Cefamandole versus cefazolin in vascular surgical wound infection prophylaxis: cost-effectiveness and risk factors.
    Edwards WH; Kaiser AB; Tapper S; Edwards WH; Martin RS; Mulherin JL; Jenkins JM; Roach AC
    J Vasc Surg; 1993 Sep; 18(3):470-5; discussion 475-6. PubMed ID: 8377241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial.
    Maki DG; Bohn MJ; Stolz SM; Kroncke GM; Acher CW; Myerowitz PD
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1423-34. PubMed ID: 1434726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic prophylaxis in open-heart surgery: a comparison of cefamandole, cefuroxime, and cefazolin.
    Gentry LO; Zeluff BJ; Cooley DA
    Ann Thorac Surg; 1988 Aug; 46(2):167-71. PubMed ID: 3401076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections.
    Kernodle DS; Classen DC; Burke JP; Kaiser AB
    JAMA; 1990 Feb; 263(7):961-6. PubMed ID: 2299764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of cefamandole, cefazolin, and cefuroxime prophylaxis in open-heart surgery.
    Slama TG; Sklar SJ; Misinski J; Fess SW
    Antimicrob Agents Chemother; 1986 May; 29(5):744-7. PubMed ID: 3524428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients.
    Kaiser AB; Petracek MR; Lea JW; Kernodle DS; Roach AC; Alford WC; Burrus GR; Glassford DM; Thomas CS; Stoney WS
    Ann Surg; 1987 Dec; 206(6):791-7. PubMed ID: 3689015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of cefamandole, cefazolin, and cefuroxime for antibiotic prophylaxis in cardiac operations.
    Townsend TR; Reitz BA; Bilker WB; Bartlett JG
    J Thorac Cardiovasc Surg; 1993 Oct; 106(4):664-70. PubMed ID: 8412261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which cephalosporin for wound prophylaxis? An experimental comparison of three drugs.
    Scher KS; Jones CW
    Surgery; 1985 Jul; 98(1):30-4. PubMed ID: 3892746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefazolin versus cefamandole for prophylaxis during total joint arthroplasty.
    Bryan CS; Morgan SL; Caton RJ; Lunceford EM
    Clin Orthop Relat Res; 1988 Mar; (228):117-22. PubMed ID: 3342553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cefamandole and cefazolin during cardiopulmonary bypass.
    Bryan CS; Smith CW; Sutton JP; Allen WB; Blanding R; Gangemi JD
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):222-5. PubMed ID: 6348425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefuroxime versus cefazolin as prophylaxis in vascular surgery.
    Edwards WH; Kaiser AB; Kernodle DS; Appleby TC; Edwards WH; Martin RS; Mulherin JL; Wood CA
    J Vasc Surg; 1992 Jan; 15(1):35-41; discussion 41-2. PubMed ID: 1728688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic prophylaxis in open-heart surgery patients: comparison of cefamandole and cefuroxime.
    Peterson CD; Lake KD; Arom KV; Love KR
    Drug Intell Clin Pharm; 1987 Sep; 21(9):728-32. PubMed ID: 3498617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial prophylaxis for open heart operations.
    Miedzinski LJ; Callaghan JC; Fanning EA; Gelfand ET; Goldsand G; Modry D; Penkoske P; Preiksaitis J; Sheehan G; Sterns L
    Ann Thorac Surg; 1990 Nov; 50(5):800-7. PubMed ID: 2241347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting cost-effective antimicrobial prophylaxis in surgery: are we getting what we pay for?
    Roach AC; Kernodle DS; Kaiser AB
    DICP; 1990 Feb; 24(2):183-5. PubMed ID: 2309513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular surgery prophylaxis. A randomized, controlled comparison of cefazolin and cefuroxime.
    Doebbeling BN; Pfaller MA; Kuhns KR; Massanari RM; Behrendt DM; Wenzel RP
    J Thorac Cardiovasc Surg; 1990 Jun; 99(6):981-9. PubMed ID: 2193200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical prophylaxis: how far have we really come?
    Kernodle DS
    Pharmacotherapy; 1988; 8(6 Pt 2):11S-13S. PubMed ID: 3075742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials.
    Kreter B; Woods M
    J Thorac Cardiovasc Surg; 1992 Sep; 104(3):590-9. PubMed ID: 1387437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, prospective comparison of first- and second-generation cephalosporins as infection prophylaxis for cardiac surgery.
    Curtis JJ; Boley TM; Walls JT; Hamory B; Schmaltz RA
    Am J Surg; 1993 Dec; 166(6):734-7. PubMed ID: 8273859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preventive antibiotics in cardiac surgery: cefazolin versus cefamandole].
    Gérard JL; Zerr C; Lebreton P; Nivaud M; Fauchon G; Khayat A; Quesnel J
    Cah Anesthesiol; 1986 Nov; 34(7):565-70. PubMed ID: 3815140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-day cefamandole versus five-day cephazolin prophylaxis in 965 total hip replacements. Report of a multicentre double blind randomised trial.
    Evrard J; Doyon F; Acar JF; Salord JC; Mazas F; Flamant R
    Int Orthop; 1988; 12(1):69-73. PubMed ID: 3286537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.